Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Treatment of perinatal viral infections to improve neurologic outcomes
William J. Muller
*
*
Corresponding author for this work
Pediatrics
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of perinatal viral infections to improve neurologic outcomes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Central Nervous System
100%
Herpes Simplex Virus
100%
Neurological Outcome
100%
Neonatal Herpes
100%
Fetal Viral Infection
100%
Neonate
50%
Fetus
50%
Viral
50%
Viral Infection
50%
School Age
50%
Brain Development
50%
Virus
50%
High Dose
50%
AIDS/HIV
50%
Cytomegalovirus
50%
Cytomegalovirus Infection
50%
Neurocognitive Function
50%
Neurodevelopment
50%
Zika Virus
50%
Nervous System Diseases
50%
Common Mechanisms
50%
Valganciclovir
50%
Ganciclovir
50%
Virus Diseases
50%
Acyclovir
50%
Human Immunodeficiency Virus Infection
50%
Neurodevelopmental Outcome
50%
Herpes Simplex Virus Encephalitis
50%
Neurodevelopmental Abnormalities
50%
Neurologic Morbidity
50%
Early Control
50%
Susceptible Host
50%
Pleconaril
50%
Oral Acyclovir
50%
Enterovirus
50%
Enterovirus Infection
50%
Antiviral Research
50%
Oral Prodrugs
50%
Medicine and Dentistry
Virus Infection
100%
Antivirus Agent
66%
Herpes Simplex Virus
66%
Central Nervous System
66%
Neonatal Herpes Simplex
66%
Aciclovir
66%
Neonates
33%
Drug Megadose
33%
Nerve Cell Differentiation
33%
Human Immunodeficiency Virus
33%
Cytomegalovirus
33%
Human Immunodeficiency Virus Infection
33%
Brain Development
33%
Central Nervous System Infection
33%
Congenital Cytomegalovirus Infection
33%
Pleconaril
33%
Enterovirus Infection
33%
Herpes Simplex Encephalitis
33%
Zika Virus
33%
Neonatal Infant
33%
Virus
33%
Enterovirus
33%
Prodrug
33%
Valganciclovir
33%
Ganciclovir
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Virus Infection
100%
Antivirus Agent
66%
Herpes Simplex Virus
66%
Aciclovir
66%
HIV
33%
Prodrug
33%
Human Immunodeficiency Virus Infection
33%
Cytomegalovirus
33%
Cytomegalovirus Infection
33%
Herpes Simplex Encephalitis
33%
Zika Virus
33%
Central Nervous System Infection
33%
Enterovirus
33%
Enterovirus Infection
33%
Ganciclovir
33%
Valganciclovir
33%
Pleconaril
33%
Diseases
33%